Baijin Life Science HoldingsMNNGF 34 Gross Margin % is 15.39% as of Sep. 2025, which is 43% below its 10-year median of 26.86. GuruFocus rates MNNGF with a GF Score™ of 34/100 and a GF Value™ of $0.04. The stock has 6 warning signs investors should review. Among 1,113 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 65.77% on this metric.
Baijin Life Science Holdings (OTCPK:MNNGF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Baijin Life Science Holdings had a gross margin of 15.39% for the quarter that ended in Sep. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Baijin Life Science Holdings Gross Margin % Related Terms
Baijin Life Science Holdings Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Gross Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Baijin Life Science Holdings (MNNGF) has a Gross Margin % of 15.39% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Baijin Life Science Holdings and its competitors. This is 43% below median its historical median of 26.86. According to the industry distribution chart, Baijin Life Science Holdings ranks #732 out of 1113 companies in the Retail - Cyclical industry, placing it in the top 65.8%.
Is Baijin Life Science Holdings' Gross Margin % too high?
Baijin Life Science Holdings' current Gross Margin % of 15.39% is 43% below median its 10-year median of 26.86. The Retail - Cyclical industry median Gross Margin % is 36.26. Baijin Life Science Holdings' value of 15.39% is 57.6% below this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #732 out of 1113 companies in the Retail - Cyclical industry, which is below the industry midpoint. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Gross Margin % compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #732 out of 1113 companies for Gross Margin %. This places Baijin Life Science Holdings in the lower half of its industry. The industry median Gross Margin % is 36.26. Baijin Life Science Holdings' value of 15.39% is 57.6% below this benchmark. While the company's 10-year median is 26.86 vs. the industry median of 36.26, Baijin Life Science Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Retail - Cyclical company?
The median Gross Margin % among Retail - Cyclical companies is 36.26, based on 1,113 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Gross Margin % of 15.39% is 57.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Gross Margin % is 36.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Gross Margin % is 15.39%, which is 43% below median its own 10-year median of 26.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Gross Margin % of 15.39%. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Gross Margin % is 15.39%, which is 43% below median its 10-year median of 26.86 and 57.6% below the Retail - Cyclical industry median of 36.26. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Gross Margin % is 15.39% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.
Key valuation signals for MNNGF:
Gross Margin %: 15.39% (43% below median its 10-year median of 26.86)
GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
Industry Position: 57.6% below the Retail - Cyclical median (#732 of 1113)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score
Get the complete analysis for MNNGF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
